Eurobio Scientific Société anonyme (ALERS.PA)
EUR 25.35
(0.0%)
EUR 25.35
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 130.64 Million EUR | -14.81% |
| 2022 | 152.6 Million EUR | -17.38% |
| 2021 | 184.71 Million EUR | -2.19% |
| 2020 | 188.85 Million EUR | 217.54% |
| 2019 | 59.47 Million EUR | 16.46% |
| 2018 | 51.07 Million EUR | 19.38% |
| 2017 | 42.78 Million EUR | 53.75% |
| 2016 | 27.82 Million EUR | -6.56% |
| 2015 | 29.78 Million EUR | -4.07% |
| 2014 | 31.04 Million EUR | -0.55% |
| 2013 | 31.21 Million EUR | 479.47% |
| 2012 | 5.38 Million EUR | 7.89% |
| 2011 | 4.99 Million EUR | -38.89% |
| 2010 | 8.17 Million EUR | 67.03% |
| 2009 | 4.89 Million EUR | 15.95% |
| 2008 | 4.21 Million EUR | -21.65% |
| 2007 | 5.38 Million EUR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 73.45 Million EUR | 0.0% |
| 2023 Q4 | 71.27 Million EUR | 0.0% |
| 2023 FY | 130 Million EUR | -14.81% |
| 2023 Q2 | 59.15 Million EUR | 0.0% |
| 2022 Q2 | 83.75 Million EUR | 0.0% |
| 2022 FY | 152.6 Million EUR | -17.38% |
| 2022 Q4 | 68.85 Million EUR | 0.0% |
| 2021 Q4 | 88.98 Million EUR | 0.0% |
| 2021 FY | 184.71 Million EUR | -2.19% |
| 2021 Q2 | 95.73 Million EUR | 0.0% |
| 2020 FY | 188.85 Million EUR | 217.54% |
| 2020 Q4 | 126.6 Million EUR | 0.0% |
| 2020 Q2 | 62.24 Million EUR | 0.0% |
| 2019 FY | 59.47 Million EUR | 16.46% |
| 2019 Q2 | 29.62 Million EUR | 0.0% |
| 2019 Q4 | 29.58 Million EUR | 0.0% |
| 2018 Q4 | 26.02 Million EUR | 0.0% |
| 2018 Q2 | 25.04 Million EUR | 0.0% |
| 2018 FY | 51.07 Million EUR | 19.38% |
| 2017 Q4 | 23.24 Million EUR | 0.0% |
| 2017 FY | 42.78 Million EUR | 53.75% |
| 2017 Q2 | 19.53 Million EUR | 0.0% |
| 2016 Q2 | 15.04 Million EUR | 0.0% |
| 2016 FY | 27.82 Million EUR | -6.56% |
| 2016 Q4 | 12.78 Million EUR | 0.0% |
| 2015 Q4 | 13.79 Million EUR | 0.0% |
| 2015 Q2 | 15.98 Million EUR | 0.0% |
| 2015 FY | 29.78 Million EUR | -4.07% |
| 2014 Q2 | 16.15 Million EUR | 0.0% |
| 2014 Q4 | 14.89 Million EUR | 0.0% |
| 2014 FY | 31.04 Million EUR | -0.55% |
| 2013 Q4 | 15.31 Million EUR | 0.0% |
| 2013 Q2 | 15.9 Million EUR | 0.0% |
| 2013 FY | 31.21 Million EUR | 479.47% |
| 2012 Q2 | - EUR | -100.0% |
| 2012 FY | 5.38 Million EUR | 7.89% |
| 2012 Q4 | - EUR | -100.0% |
| 2012 Q3 | 1.34 Million EUR | 0.0% |
| 2012 Q1 | 1.34 Million EUR | 0.0% |
| 2011 Q4 | - EUR | -100.0% |
| 2011 Q2 | - EUR | -100.0% |
| 2011 FY | 4.99 Million EUR | -38.89% |
| 2011 Q3 | 1.24 Million EUR | 0.0% |
| 2011 Q1 | 1.24 Million EUR | 0.0% |
| 2010 Q1 | 2.04 Million EUR | 0.0% |
| 2010 FY | 8.17 Million EUR | 67.03% |
| 2010 Q4 | - EUR | -100.0% |
| 2010 Q3 | 2.04 Million EUR | 0.0% |
| 2010 Q2 | - EUR | -100.0% |
| 2009 Q1 | 1.22 Million EUR | 15.95% |
| 2009 Q4 | - EUR | -100.0% |
| 2009 Q3 | 1.22 Million EUR | 0.0% |
| 2009 Q2 | 1.22 Million EUR | 0.0% |
| 2009 FY | 4.89 Million EUR | 15.95% |
| 2008 FY | 4.21 Million EUR | -21.65% |
| 2008 Q1 | 1.05 Million EUR | -21.65% |
| 2008 Q2 | 1.05 Million EUR | 0.0% |
| 2008 Q3 | 1.05 Million EUR | 0.0% |
| 2008 Q4 | 1.05 Million EUR | 0.0% |
| 2007 Q4 | 1.34 Million EUR | 0.0% |
| 2007 Q2 | 1.34 Million EUR | 0.0% |
| 2007 Q3 | 1.34 Million EUR | 0.0% |
| 2007 Q1 | 1.34 Million EUR | 0.0% |
| 2007 FY | 5.38 Million EUR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Affluent Medical SA | 1.22 Million EUR | -10573.693% |
| Bluelinea Société Anonyme | 9826.00 EUR | -1329494.942% |
| Carmat SA | 2.84 Million EUR | -4487.289% |
| Diagnostic Medical Systems S.A. | 42.15 Million EUR | -209.933% |
| Euromedis Groupe | 37.42 Million EUR | -249.054% |
| Ikonisys S.A. | 448.55 Thousand EUR | -29025.841% |
| Implanet S.A. | 7.44 Million EUR | -1654.344% |
| Median Technologies SA | 22.22 Million EUR | -487.807% |
| SpineGuard SA | 4.31 Million EUR | -2929.263% |
| Theraclion SA | 1.82 Million EUR | -7069.602% |
| Euroapi S.A. | 1.01 Billion EUR | 87.178% |
| Guerbet SA | 785.69 Million EUR | 83.372% |
| Ion Beam Applications SA | 428.71 Million EUR | 69.526% |
| Koninklijke Philips N.V. | 18.16 Billion EUR | 99.281% |
| Sequana Medical NV | 712.17 Thousand EUR | -18244.7% |